Skip to main content

Zuplenz FDA Approval History

Last updated by Judith Stewart, BPharm on Aug 1, 2023.

FDA Approved: Yes (Discontinued) (First approved July 2, 2010)
Brand name: Zuplenz
Generic name: ondansetron
Dosage form: Oral Soluble Film
Company: Aquestive Therapeutics
Treatment for: Nausea/Vomiting, Chemotherapy Induced, Nausea/Vomiting, Postoperative, Nausea/Vomiting, Radiation Induced

Zuplenz (ondansetron) is an oral soluble film formulation of the approved 5-HT3 receptor antagonist ondansetron for the prevention of nausea and vomiting associated with chemotherapy, nausea and vomiting associated with radiotherapy, and postoperative nausea and/or vomiting.

Development timeline for Zuplenz

DateArticle
Jul  5, 2010Approval FDA Approves Strativa Pharmaceuticals' Zuplenz (ondansetron) Oral Soluble Film

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.